Clobederm 0.05% (Cream)
Medicine Details
Category | Details |
---|---|
Generic | Clobetasol propionate |
Company | Drug international ltd |
Also available as |
Indications
- Psoriasis (excluding widespread plaque psoriasis)
- Recalcitrant dermatoses
- Lichen planus
- Discoid lupus erythematosus
- Other skin conditions which do not respond satisfactorily to less potent steroids
Composition
- Clobetasol Propionate Cream: 0.05% w/w
- Clobetasol Propionate Ointment: 0.05% w/w
- Clobetasol Propionate Scalp Application: 0.05% w/w
- Clobetasol Propionate Shampoo: 0.05% w/w
- Clobetasol Propionate Lotion: 0.05% w/w
- Clobetasol Propionate Spray: 0.05% w/w
Pharmacology
Clobetasol Propionate is a very potent topical corticosteroid with anti-inflammatory, antipruritic and vasoconstrictive properties.
Dosage
- Cream, Ointment:
- Apply a thin layer twice daily
- Limited to 2 consecutive weeks
- Maximum weekly dose: 50 gm
- Spray: Apply once or twice daily; total dose applied should not exceed 50 ml weekly
- Shampoo: Apply to dry scalp once a day; treatment limited to 4 consecutive weeks
- Scalp Solution: Apply once or twice daily; total dose should not exceed 50 ml weekly
Administration
Route of administration: Cutaneous. Creams are especially appropriate for moist or weeping surfaces. Ointments are especially appropriate for dry, lichenified or scaly lesions.
Interaction
Co-administered drugs that can inhibit CYP3A4 have been shown to inhibit the metabolism of corticosteroids.
Contraindications
- Rosacea, acne vulgaris and perioral dermatitis
- Hypersensitivity to the preparation
- Primary cutaneous viral infections
- Dermatoses in children under one year of age
Side Effects
- Systemic absorption
- Atrophic changes in the skin
- Pustular form of the disease
- Pigmentation changes and hypertrichosis
Pregnancy & Lactation
Use during pregnancy and lactation should be considered in comparison to the expected benefit to the mother.
Precautions & Warnings
- Long-term continuous topical therapy to be avoided
- Atrophic changes after prolonged treatment
- Care needed when applying to eyelids
- Hazardous in psoriasis
- Use in infants and children
Use in Special Populations
In infants and children under 12 years of age, long-term continuous topical corticosteroid therapy should be avoided.
Overdose Effects
Acute overdosage is very unlikely, chronic over-dosage or misuse may lead to hypercortisolism.
Therapeutic Class
- Other Topical corticosteroids
Storage Conditions
Keep below 30°C, protected from light and moisture, do not freeze.